Please login to the form below

Not currently logged in
Email:
Password:

Zeltiq Aesthetics

This page shows the latest Zeltiq Aesthetics news and features for those working in and with pharma, biotech and healthcare.

Allergan adds Zeltiq to M&A roster in $2.48n deal

Allergan adds Zeltiq to M&A roster in $2.48n deal

Expands aesthetic pharma business with “best-in-class” body contouring system. Botox manufacturer Allergan has bolstered its cosmetic product portfolio once again, signing a $2.48bn agreement to buy Zeltiq Aesthetics. ... The Zeltiq acquisition marks

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Following its spate of deals last year, Allergan is paying $2.48bn ($56.50 per share, a 14.4% premium) to acquire ZELTIQ Aesthetics to enhance its global medical aesthetics portfolio. ... Royalty monetisation. 2, 850. ZELTIQ Aesthetics/ Allergan.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Genoscience Pharma expands board of directors Genoscience Pharma expands board of directors

    He most recently served as Pharmcyclics' chief financial officer and treasurer and has also held management positions at ZELTIQ Aesthetics and PriceWaterhouseCoopers, where he worked in PwC's San Jose office

  • Versartis names chief financial officer Versartis names chief financial officer

    He already has life sciences financial experience, having previously served as chief financial officer for Zeltiq Aesthetics and director of finance at Proteolix.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....